Skip to main content

Hilltop Partners LLC

SEC CIK
0001957867
Latest filing
Aug 5, 2026

ENDV holding history

Endonovo Therapeutics, Inc. in every 13F filed by Hilltop Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENDV overviewAll 13F holders of ENDVFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2025
Holdings of ENDV by Hilltop Partners LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−20,228−100.0%Sold outHolders
Q2 202520,228$3<0.1%+20,228NewHolders